China SXT Pharmaceuticals, Inc. - Equity Offering

On April 7, 2026, China SXT Pharmaceuticals, Inc. entered into a securities purchase agreement with certain investors to sell and issue 2,000,000 Class A Ordinary Shares. The offering is expected to raise approximately $760,000 in gross proceeds, before deducting expenses. The company intends to use the net proceeds for general corporate purposes. The offering is being made pursuant to a previously effective registration statement on Form F-3 and a prospectus supplement filed on April 9, 2026. The offering was expected to close on April 9, 2026, subject to customary closing conditions.